These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9214240)

  • 1. [Gaucher's disease: results of enzymatic treatment with beta glucosidase acid].
    Genovés Terol I; Martínez Porcal C; Ferrrer Lorente B; Menor Serrano F; Dalmau Serra J
    An Esp Pediatr; 1997 Apr; 46(4):406-8. PubMed ID: 9214240
    [No Abstract]   [Full Text] [Related]  

  • 2. Case 20-2003: Gaucher's disease.
    Beutler E
    N Engl J Med; 2004 Jan; 350(4):416-7; discussion 416-7. PubMed ID: 14736939
    [No Abstract]   [Full Text] [Related]  

  • 3. Repacement therapy in Gaucher disease.
    Beutler E; Dale GL; Kuhl W
    Birth Defects Orig Artic Ser; 1980; 16(1):369-81. PubMed ID: 6778528
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase.
    Gregoriadis G; Neerunjun D; Meade TW; Goolamali SK; Weereratne H; Bull G
    Birth Defects Orig Artic Ser; 1980; 16(1):383-92. PubMed ID: 6778529
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.
    Michelin K; Wajner A; Goulart Lda S; Fachel AA; Pereira ML; de Mello AS; Souza FT; Pires RF; Giugliani R; Coelho JC
    Clin Chim Acta; 2004 May; 343(1-2):145-53. PubMed ID: 15115687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy].
    Castelló Girona F; Domínguez Luengo C; del Toro Riera M; Chabás Bergon A
    An Esp Pediatr; 2001 Mar; 54(3):310-2. PubMed ID: 11262263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological diagnosis of Gaucher's disease].
    Berhoune A; Zenati A; Bellahsene Z; Khiari M; Maiza H; Zighout M; Khati S; Oukaci Y; Khati B
    Tunis Med; 1980; 58(1-2):452-7. PubMed ID: 6782723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of studying isoenzymes in hereditary lysosomal lipidoses. In particular beta-glucosidase (Gaucher's disease) and acid lipase (Wolman's disease and cholesterol ester storage disease)].
    Douste-Blazy L; Nègre A; Maret A; Salvayre R
    Bull Acad Natl Med; 1985 Jan; 169(1):58-65. PubMed ID: 3926252
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte beta-glucosidase in a child with Gaucher's disease and his kinship.
    László A; Ilyés M; Klujber L
    Acta Paediatr Hung; 1984; 25(3):237-40. PubMed ID: 6437419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New directions in the treatment of Gaucher disease.
    Futerman AH; Sussman JL; Horowitz M; Silman I; Zimran A
    Trends Pharmacol Sci; 2004 Mar; 25(3):147-51. PubMed ID: 15019270
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept.
    Gregoriadis G
    Ann N Y Acad Sci; 1978; 308():343-70. PubMed ID: 100040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gaucher's disease. Report of 4 cases].
    Adarraga Cansino MD; Fernández de la Puebla R; Jiménez Perepérez JA; Pocoví Mieras M; Zambrana García JL; Pérez Jiménez F
    Rev Clin Esp; 2002 Dec; 202(12):635-7. PubMed ID: 12459090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communicating hydrocephalus in a patient with Gaucher's disease type 3.
    Shiihara T; Oka A; Suzaki I; Ida H; Takeshita K
    Pediatr Neurol; 2000 Mar; 22(3):234-6. PubMed ID: 10734257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).
    Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY
    J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of type I Gaucher's disease in Spain. Preliminary results of national survey. Spanish Group on Gaucher's Disease].
    Giraldo P; Pérez-Calvo JI; Giralt M; Pocovi M
    Med Clin (Barc); 1997 Nov; 109(16):619-22. PubMed ID: 9463135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW
    Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.
    Beutler E; Beutler L; West C
    J Lab Clin Med; 2004 Aug; 144(2):65-8. PubMed ID: 15322500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease.
    Compain P; Martin OR; Boucheron C; Godin G; Yu L; Ikeda K; Asano N
    Chembiochem; 2006 Sep; 7(9):1356-9. PubMed ID: 16871601
    [No Abstract]   [Full Text] [Related]  

  • 20. [An adult form of type-I. Gaucher's disease].
    Múzes G; Pitlik E; Gohér A; Somogyi A; Tulassay Z
    Orv Hetil; 2000 Mar; 141(13):669-73. PubMed ID: 10774238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.